Royal Bank of Canada »

BioCryst Pharmaceuticals shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2011-09-30 $6.0k 2.3k 2.59
2011-06-30 $5.0k 1.2k 4.17

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Bk Nova Cad (BNS)
Ishares Tr Russell 2000 Etf (IWM)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
Kynam Capital Management
State Street Corporation
Deerfield Management Company
Alkeon Capital Management
Geode Capital Management
Nuveen Asset Management
RP Management
Rock Springs Capital Management
Fisher Investments
Jennifer Ranahan
Caligan Partners
Goldman Sachs Group

View all funds holding BioCryst Pharmaceuticals